Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc. (NASDAQ: AMED) is a leading healthcare services company in the United States, specializing in delivering personalized home health, hospice, and high-acuity care services. Headquartered in Baton Rouge, LA, with an executive office in Nashville, TN, the company employs around 18,700 staff across 520 care centers in 37 states and the District of Columbia. Founded in 1982, Amedisys is dedicated to providing quality, clinically-distinctive care to more than 469,000 patients annually, with over 10.6 million visits each year.
Amedisys operates across four key segments: Home Health, Hospice, High Acuity Care, and Personal Care. The Home Health segment offers skilled nursing, therapy, and aid services directly in patients' homes, while the Hospice segment provides end-of-life care to terminally ill patients. The High Acuity Care segment delivers critical inpatient care elements at home, and the Personal Care segment, which was divested in March 2023, offered assistance with daily living activities.
Amedisys's commitment to high-quality care is underpinned by its comprehensive coordination with healthcare providers and personalized care plans tailored to each patient's unique needs. With a strong network involving more than 3,000 hospitals and 110,000 physicians nationwide, Amedisys is a trusted partner in post-acute care.
Recent notable achievements include a merger agreement with UnitedHealth Group, aimed at enhancing patient care through integrated services. Financially, Amedisys reported a net service revenue increase to $571.4 million for Q1 2024, reflecting a robust service demand despite divesting the Personal Care segment.
Additionally, Amedisys is actively involved in advancing healthcare technology. The company has partnered with Patient Choice Laboratories to incorporate advanced molecular testing, enhancing infection diagnosis and patient outcomes. This innovation underscores Amedisys’s commitment to leveraging cutting-edge technology to improve patient care.
For stakeholders, Amedisys remains a prominent figure in the home healthcare industry, constantly adapting and growing to meet the increasing needs of its patient population. The company's strategic partnerships and advancements in healthcare technology position it well for sustained growth and improved patient outcomes.
Amedisys, a leading home health, hospice, and personal care company, announces presentations by key executives Paul B. Kusserow, Chris Gerard, and Scott Ginn at significant upcoming conferences. They will be presenting at the William Blair Growth Stock Conference on June 3, 2021, at 1:00 p.m. ET, and at the Jefferies Virtual Healthcare Conference on June 4, 2021, at 9:00 a.m. ET. Amedisys serves over 418,000 patients annually through its extensive network of care centers across the U.S., focusing on personalized healthcare solutions.
Amedisys, a leading home health and hospice company, has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare. This annual recognition honors 150 organizations that empower employees to deliver quality care. Amedisys' CEO and HR Chief highlighted the importance of a supportive culture, especially during the pandemic, contributing to reduced turnover and enhanced employee engagement. The full ranking will be released on September 16, 2021.
Amedisys (NASDAQ: AMED) is set to transition home health and hospice operations from the Visiting Nurse Association (VNA) on July 1, 2021. This move aligns with VNA's mission to focus on community needs amid evolving healthcare demands. Amedisys aims to enhance its resources and scale, thereby expanding service access in Nebraska and Iowa. VNA will continue offering essential community programs, ensuring that underserved individuals receive care through Amedisys’ existing services.
Amedisys, a prominent home healthcare company, is set to present at the 2021 RBC Capital Markets Healthcare Conference on May 18, 2021. The presentation will be delivered by Paul B. Kusserow, CEO, and Chris Gerard, COO, starting at 1:20 p.m. Eastern Time. Interested investors can access the live webcast through Amedisys' investor website. Founded in 1982, Amedisys operates 514 care centers across 39 states, delivering high-quality home health, hospice, and personal care services to over 418,000 patients annually.
Amedisys, Inc. (NASDAQ: AMED), a prominent provider of home health, hospice, and personal care, has successfully completed its acquisition of regulatory assets enabling operations in Randolph County, N.C. This acquisition allows Amedisys to offer certified home health care services to a market of 31,000 Medicare and Medicare Advantage enrollees. Amedisys plans to establish a start-up care center in the area, further expanding its services and reinforcing its position as a leader in home-based health care.
Amedisys, Inc. (NASDAQ: AMED), a prominent home health and hospice provider, announced that key executives, including Chairman and CEO Paul B. Kusserow, will present at the 2021 Bank of America Healthcare Conference on May 11, 2021, at 4:15 p.m. ET. Interested parties can access the live webcast via Amedisys' investor relations website. Amedisys has over 21,000 employees across 514 care centers nationwide, serving more than 418,000 patients annually, showcasing the company's commitment to high-quality home health services.
Amedisys, Inc. (NASDAQ: AMED) reported strong financial results for Q1 2021, with net service revenue increasing by $45.4 million to $537.1 million compared to $491.7 million in Q1 2020. Net income rose to $49.9 million ($1.50 per diluted share) from $31.8 million ($0.96 per diluted share) the previous year. Adjusted EBITDA also saw growth, reaching $78.6 million versus $53.3 million in 2020. The company updated its 2021 guidance, projecting revenue between $2.302 billion and $2.342 billion, while adjusted EBITDA is expected to range from $342 million to $352 million.
Amedisys, Inc. (NASDAQ: AMED) is launching the Home Health Advanced Program in collaboration with Sound Physicians, set to begin in mid-May 2021. This initiative targets Medicare FFS patients with specific diagnoses and acuity levels, offering personal care and telemedicine services at no extra cost. Amedisys emphasizes its commitment to high-quality home care for higher acuity patients, expanding its Personal Care Network across 39 states with 1,500 agencies. The program is designed to improve care quality and reduce costs for patients transitioning from hospitals to home.
Amedisys, Inc. (NASDAQ: AMED) will announce its first-quarter results for the period ending March 31, 2021, on April 28, 2021. An investor conference call is scheduled for April 29, 2021, at 11:00 a.m. ET to discuss these results. Interested parties can join the call by dialing (877) 524-8416 for toll-free or (412) 902-1028 for toll access. A replay will be available until May 29, 2021. Amedisys is a prominent provider of home health, hospice, and personal care services, serving over 418,000 patients annually with a network of 514 care centers across the U.S.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
What services does Amedisys Inc. provide?
Where is Amedisys Inc. headquartered?
How many employees does Amedisys have?
What is the scope of Amedisys's operations?
How many patients does Amedisys serve annually?
What recent merger has Amedisys entered into?
What recent technological advancement has Amedisys incorporated?
What was Amedisys's net service revenue for Q1 2024?
How does Amedisys coordinate patient care?
What was the Personal Care segment of Amedisys?
